Trending News
News
News
Valeant Pharmaceuticals To Acquire Sprout Pharmaceuticals
Valeant and Sprout Pharmaceuticals have announced that they have entered into a definitive agreement under which a wholly-owned subsidiary of Valeant will acquire Sprout for approximately $1 billion in cash, plus a share of future profits based upon the achievement of certain milestones.
News
X-ray Laser Experiment Could Help in Designing Drugs for Brain Disorders
Scientists found that when two protein structures in the brain join up, they act as an amplifier for a slight increase in calcium concentration, triggering a gunshot-like release of neurotransmitters from one neuron to another.
News
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
News
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
News
EU Approves Novartis's laBCC Therapy
Novartis has announced that the European Commission has approved Odomzo® 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) who are not amenable to curative surgery or radiation therapy.
News
New Center Will Advance Life-Saving Genome-Based Diagnostic Tools
UCSF-designed tests pinpoint rare infectious agents far more rapidly than conventional methods.
News
Nottingham Gets "Grow Ahead" for New £30m Life Science Facility
Hundreds of highly skilled jobs are expected to be created and safeguarded in Nottingham with the news that work can now start on a new £30m life science building adjacent to the current BioCity site on Pennyfoot Street.
News
BioLineRx Reports Second Quarter 2015 Financial Results
Company to initiate a pivotal CE Mark registration study for BL-7010 in the fourth quarter of 2015.
News
Success In Using Zebrafish Embryos to Identify Potential New Diabetes Drugs
In experiments with 500,000 genetically engineered zebrafish embryos, Johns Hopkins scientists report they have developed a potentially better and more accurate way to screen for useful drugs, and they have used it to identify 24 drug candidates that increase the number of insulin-producing cells in the pancreas.
News
Protein Clumps in Autopsy Brain Cells of ALS Patients Explained
Autopsies of nearly every patient with the lethal neurodegenerative disorder amyotrophic lateral sclerosis (ALS), and many with frontotemporal dementia (FTD), show pathologists telltale clumps of a protein called TDP-43.
Advertisement